Abstract
In many disease conditions, selectivity in drug delivery would be of considerable advantage. Cancer chemotherapy is the often quoted example where antitumor drugs can destroy the target (tumor cells) but can also have an undesirable effect on non-target cells. This chapter will focus on the possibilities and pitfalls of attempting drug targeting using physical approaches such as colloidal particles in the form of microspheres, liposomes or emulsions. Firstly, the feasibility of targeting needs to be considered. In some attempts at so called ‘Drug targeting’, it can be overlooked that the target may not be well defined. Certainly it is important to decide at a very early stage what one is aiming at, and whether the target is discrete and accessible. In addition, some differences between target and non-target must be discernible.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Alving, C. R., Steck, E. A., Hanson, W. L., Loizeaux, P. S., Chapman, W. L., and Waits, V. B., 1978, Improved therapy of experimental leishmaniasis by use of a liposome-encapsulated antimonial drug, Life Sci., 22:1021.
Artursson, P., Edman, P., Laakso, T., and Sjoholm, I., 1984, Characterization of polyacryl starch microspheres as carriers for proteins and drugs, J.Pharm.Sci., 73:1507.
Baldwin, R. W., and Byers, V. S., 1986, Monoclonal antibody targeting of anti-cancer agents, Springer Semin.Immunopathol., 9:39.
Bonté, F., and Juliano, R. L., Interaction of liposomes with serum proteins, Chem.Phys.Lip., 40:359.
Cannor, J., Norley, N., and Huang, L., 1986, Biodistribution of pH-sensi-tive immunoliposomes, Biochim.Biophys.Acta., 884:474.
Croft, S. L., 1986, Liposomes in the treatment of parasitic disease, Parm.Internat., 7:229.
Davis, S. S., Douglas, S. J, Ilium, L., Jones, P. D. E., Mak, E., and Muller, R., 1986a, Passive and active delivery of colloidal carriers and the role of surface modifications, in: “Targeting of Drugs with Synthetic Systems,” G. Gregoriadis, J. Senior, and G. Poste, eds., Plenum Press, New York.
Davis, S. S., Hardy, J. G., and Fara, J. W., 1986b, Transit of pharmaceutical dosage forms through the small intestine, Gut, 27:886.
Davis, S. S., and Ilium, L., 1986, Colloidal delivery systems: Opportunities and challenges, in: “Site Specific Delivery,” E. Tomlinson, and S. S. Davis, eds., Wiley, Chichester.
Davis, S. S., Washington, C., West, P., Ilium, L., Liversidge, G., Sternson, L., and Kirsh, R., 1987, Lipid emulsions as drug delivery systems, Annal.New York Acad.Sci., in press.
Deshmukh, D. S., Beer, W. D., and Brockerhoff, H., 1981, Can intact liposomes be adsorbed from the gut? Life Sci., 28:239.
Gabev, E. E., Svilenov, D. K., Poljakakova-Krusteva, O. T., and Vassilev, I., 1985, Brain, liver and spleen detection of liposomes after rectal administration, J.Microencapsulation, 2:85.
Gregoriadis, G., 1981, Targeting of drugs, Implications in medicine, Lancet, 2:241.
Ilium, L., and Davis, S. S., 1984, The organ uptake of intravenously administered colloidal particles can be altered using a nonionic surfactant (poloxamer 338), FEBS Lett., 167:79.
Ilium, L., and Davis, S. S., 1987, Targeting of microspheres to the bone marrow, Life Sci., 40:1553.
Ilium, L., Jones, P. D. E., Baldwin, R. W., and Davis, S. S., 1984, Tissue distribution of poly(hexyl-2-cyanacrylate) nanoparticles coated with monoclonal antibodies in mice bearing human tumor xenografts, J.Pharmacol.Exper.Therapeut., 230:733.
Ilium, L., Davis, S. S., Wilson, C. G., Frier, M., Hardy, J. G., and Thomas, N. W., 1982, Blood clearance and organ deposition of intravenously administered colloidal particles; the effects of particle size, nature and shape, Intern.J.Pharmaceut., 12:135.
Juliano, R. L., 1983, Interactions of proteins and drugs with liposomes, in: “Liposomes,” M. Ostro, ed., Marcel Dekker, New York.
Kao, Y. J., and Juliano, R. L., 1981, Interaction of liposomes with the reticuloendothelial system: effects of blockade on the clearance of large unilamellar vesicles, Biochim.Biophys.Acta., 677:453.
Khosla, R., and Davis, S. S., 1987, The effect of polycarbophil on the gastric emptying of pellets, J.Pharm.Pharmac., 39:47.
Nishihata, T., Miyake, M., Takahata, H., and Kamada, A., 1986, The effect of adjuvants on the colonic adsorption of cefmetazole and [ASU1, 7]-eel calcitonin in rats: concentration dependent adsorption path-ways, Int.J.Pharmaceut., 33:89.
Poste, G., 1984, Drug Targeting in Cancer Chemotherapy in: “Receptor-mediated Targeting of Drugs,” G. Gregoriadis, G. Poste, J. Senior, and A. Trouet, eds., Plenum Press, New York.
Poznansky, M. S., and Juliano, R. L., 1984, Biological approaches to the controlled delivery of drugs: a critical review, Pharmaco1. Rev., 36:277.
Scherphof, G., Damen, J., and Hoekstra, P., 1981, Interactions of liposomes with plasma proteins and components of the immune system in: “Liposomes from Physical Structure to Therapeutic Application,” C. G. Knight, ed., Elsevier-North Holland, Amsterdam.
Schwinke, D. L., Ganesan, M. G., and Weiner, N. D., 1984, Effect of entrapped markers on the in situ jejunal uptake form liposomal systems, Pharm.Res., 6:256.
Simionescu, M., Simionescu, N., and Palade, G. E., 1974, Morphometric data on the endothelium of blood capillaries, J.Cell.Biol., 60:128.
Wachsmann, D., Klein, J. P., Scholler, M., and Frank, R. M., 1985, Local and systemic immune response to orally administered liposome associated soluble S.mutans cell wall antigens, Immunology, 54:189.
Weinstein, J. N., and Leserman, L. D., 1984, Liposomes ad drug carriers in cancer chemotherapy, Pharmac.Ther., 24:207.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1988 Plenum Press, New York
About this chapter
Cite this chapter
Davis, S.S., Illum, L. (1988). Targeting Using Physical Approaches and Particulate Drug Carriers: Interaction with the Biological Milieu. In: Gregoriadis, G., Poste, G. (eds) Targeting of Drugs. NATO ASI Series, vol 155. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-5574-8_16
Download citation
DOI: https://doi.org/10.1007/978-1-4684-5574-8_16
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-5576-2
Online ISBN: 978-1-4684-5574-8
eBook Packages: Springer Book Archive